A Phase II, Open-Label, Study of Propylene Glycol-Free Melphalan HCL (EVOMELA®) in Combination with Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Protocol No
IIT-HAMADANI-FLU-MEL-TBI
Principal Investigator
Mehdi Hamadani
Phase
II
Summary
To find out the safety and tolerability of reduced intensity conditioning (RIC) consisting of Propyhlene Glycol-Free Melphalan HCI (EVOMELA) in combination with Fludarabine and Total Body Irradiation (TBI) for subjects undergoing Haplo Identical (which involves matching your tissue type with a related or unrelated donor) Hematopoietic Cell Transplantation (Haplo-HCT).
Description
EVOMELA In Combination With Fludarabine and TBI based reduced intensity conditioning for Haplo BMT
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Share This: